The 36-month beta value for EYEN is at 1.75. Analysts have varying views on the stock, with 1 analysts rating it as a “buy,” 1 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for EYEN is 68.28M, and currently, shorts hold a 2.93% of that float. The average trading volume for EYEN on September 19, 2024 was 1.75M shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
EYEN) stock’s latest price update
The stock price of Eyenovia Inc (NASDAQ: EYEN) has jumped by 0.18 compared to previous close of 0.50. Despite this, the company has seen a fall of -7.60% in its stock price over the last five trading days. prnewswire.com reported 2024-09-09 that TAIPEI, Sept. 9, 2024 /PRNewswire/ — Formosa Pharmaceuticals, Inc. (hereinafter referred to as “Formosa Pharma,” 6838.TW) announced the successful first shipment to the United States of its new ophthalmic drug, Clobetasol Propionate Ophthalmic Suspension, 0.05% (APP13007), manufactured by Bora Pharmaceuticals Ophthalmic (hereinafter referred to as “Bora,” 6472.TW).
EYEN’s Market Performance
Eyenovia Inc (EYEN) has seen a -7.60% fall in stock performance for the week, with a -26.36% decline in the past month and a -22.94% plunge in the past quarter. The volatility ratio for the week is 8.12%, and the volatility levels for the past 30 days are at 13.45% for EYEN. The simple moving average for the past 20 days is -6.36% for EYEN’s stock, with a -56.73% simple moving average for the past 200 days.
Analysts’ Opinion of EYEN
Many brokerage firms have already submitted their reports for EYEN stocks, with Northland Capital repeating the rating for EYEN by listing it as a “Outperform.” The predicted price for EYEN in the upcoming period, according to Northland Capital is $10 based on the research report published on March 01, 2021 of the previous year 2021.
EYEN Trading at -41.52% from the 50-Day Moving Average
After a stumble in the market that brought EYEN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -80.51% of loss for the given period.
Volatility was left at 13.45%, however, over the last 30 days, the volatility rate increased by 8.12%, as shares surge +5.83% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -47.60% lower at present.
During the last 5 trading sessions, EYEN fell by -9.22%, which changed the moving average for the period of 200-days by -65.59% in comparison to the 20-day moving average, which settled at $0.5363. In addition, Eyenovia Inc saw -75.92% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at EYEN starting from Rowe Michael M, who purchase 27,071 shares at the price of $0.52 back on Aug 28 ’24. After this action, Rowe Michael M now owns 109,998 shares of Eyenovia Inc, valued at $14,077 using the latest closing price.
Rowe Michael M, the Chief Executive Officer of Eyenovia Inc, purchase 50,000 shares at $0.57 during a trade that took place back on Aug 26 ’24, which means that Rowe Michael M is holding 82,927 shares at $28,500 based on the most recent closing price.
Stock Fundamentals for EYEN
Current profitability levels for the company are sitting at:
- -989.57 for the present operating margin
- -43.64 for the gross margin
The net margin for Eyenovia Inc stands at -1187.13. The total capital return value is set at -9.88. Equity return is now at value -914.66, with -154.24 for asset returns.
Based on Eyenovia Inc (EYEN), the company’s capital structure generated 1.19 points at debt to capital in total, while cash flow to debt ratio is standing at -2.06. The debt to equity ratio resting at -6.21. The interest coverage ratio of the stock is -22.95.
Currently, EBITDA for the company is -24.62 million with net debt to EBITDA at -0.44. When we switch over and look at the enterprise to sales, we see a ratio of 1673.71. The receivables turnover for the company is 0.07for trailing twelve months and the total asset turnover is 0.0. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.43.
Conclusion
In conclusion, Eyenovia Inc (EYEN) has had a bad performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
